WHAT AND WHERE IS HEAVEN?

Does heaven exist? With well over 100,000 plus recorded and described spiritual experiences collected over 15 years, to base the answer on, science can now categorically say yes. Furthermore, you can see the evidence for free on the website allaboutheaven.org.

Available on Amazon
https://www.amazon.com/dp/B086J9VKZD
also on all local Amazon sites, just change .com for the local version (.co.uk, .jp, .nl, .de, .fr etc.)

VISIONS AND HALLUCINATIONS

This book, which covers Visions and hallucinations, explains what causes them and summarises how many hallucinations have been caused by each event or activity. It also provides specific help with questions people have asked us, such as ‘Is my medication giving me hallucinations?’.

Available on Amazon
https://www.amazon.com/dp/B088GP64MW 
also on all local Amazon sites, just change .com for the local version (.co.uk, .jp, .nl, .de, .fr etc.)


Observations placeholder

Nardil

Identifier

019672

Type of Spiritual Experience

Hallucination

Number of hallucinations: 12

Background

Dysthymia, sometimes also called neurotic depression, dysthymic disorder, or chronic depression, is a mood disorder consisting of the same cognitive and physical problems as in depression, with less severe but longer-lasting symptoms. The concept was invented by Robert Spitzer as a replacement for the term "depressive personality" in the late 1970s.

A description of the experience

Phenelzine (Nardil, Nardelzine) is a non-selective and irreversible monoamine oxidase inhibitor (MAOI) of the hydrazine class which is used as an antidepressant and anxiolytic. Along with tranylcypromine and isocarboxazid, phenelzine is one of the few non-selective MAOIs still in widespread clinical use. It is typically available in 15 mg tablets and doses usually range from 30–90 mg per day, with 15 mg every day or every other day suggested as a maintenance dose following a successful course of treatment.

Phenelzine is used primarily in the treatment of major depressive disorder (MDD). Patients with depressive symptomology characterized as "atypical", "nonendogenous", and/or "neurotic" are given phenelzine. The medication is also given to patients who do not respond favorably to first and second-line treatments for depression, or are "treatment-resistant".  In addition to being used for major depressive disorder, phenelzine is used for dysthymia, bipolar depression (BD), panic disorder (PD) social anxiety disorder (SAD) bulimia and post-traumatic stress disorder (PTSD).

Adverse effects

Common side effects of phenelzine may include dizziness, blurry vision, dry mouth, headache, lethargy, sedation, somnolence, insomnia, anorexia, weight gain or loss, nausea and vomiting, diarrhea, constipation, urinary retention, mydriasis, muscle tremors, hyperthermia, sweating, hypertension or hypotension, orthostatic hypotension, paresthesia, hepatitis, and sexual dysfunction (consisting of loss of libido and anorgasmia).

Other side effects  may include hypomania or mania, psychosis and acute liver failure, the last of which is usually only seen in people with pre-existing liver damage, old age, alcohol consumption, or viral infection.

On Jan, 1, 2016: 1,526 people reported to have side effects when taking Nardil. Among them, 12 people (0.79%) have Hallucination.

 

 On Jan, 17, 2016: 1,526 people reported to have side effects when taking Nardil. Among them, 2 people (0.13%) have Death.

Gender of people who have Death when taking Nardil  :

  Female Male
Death 50.00% 50.00%

Age of people who have Death when taking Nardil  :

  0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Death 0.00% 0.00% 0.00% 100.00% 0.00% 0.00% 0.00% 0.00%

 

 

The source of the experience

eHealthme

Concepts, symbols and science items

Concepts

Symbols

Science Items

Activities and commonsteps

Commonsteps

References